Phase II study of decitabine and gemtuzumab ozogamicin (GO) in acute myelogenous leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Background: CML patients with different types of BCR-ABL ...
LenderLive has announced that its GuardianDocs unit has introduced a new module to its FACTCheck suite: FACTCheck Tax Transcript Analysis. The new tool enables lenders to receive the FACTCheck tax ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results